Eccogene Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2040
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 10, 2027The maintenance fee for Thyroid Hormone Receptor Agonists and Use Thereof (US 11,780,825) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Ssao Inhibitors and Use Thereof (US 11,964,942) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,964,942 | Ssao Inhibitors and Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,472,769 | Ssao Inhibitors and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,291,518 | Thyroid Hormone Receptor Agonists and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,780,825 | Thyroid Hormone Receptor Agonists and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,584,751 | Substituted Imidazoles as GLP-1 Receptor Agonists In force · Medium confidence | In force | Medium confidence | |
| US 12,037,339 | Substituted Imidazoles as GLP-1 Receptor Agonists In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending